Search
Search Results
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
825PDF: 2308Supplementary: 306Appendix: 252 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1865PDF: 503SUPPLEMENTARY MATERIAL: 295GRAPHICAL ABSTRACT: 261HTML: 9 -
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3293PDF: 500Appendix: 375HTML: 24 -
Lipoprotein(a): what clinicians need to know
232PDF: 564HTML: 23 -
-
-
Applicability of obesity clinical practice guidelines in low- and middle-income countries
987PDF: 513Appendix: 136HTML: 13 -
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025
11628PDF: 7713Appendix: 1040 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
741PDF: 182Supplementary: 145Appendix: 104HTML: 27 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
730PDF: 197Supplementary: 140Appendix: 110HTML: 21 -
Epidemiology of peripartum cardiomyopathy in Africa
2197PDF: 490HTML: 80 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
127PDF: 206Supplementary: 142HTML: 17 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1052pdf: 234Supplementary Material: 38HTML: 104 -
Evolving targets for heart failure: the journey so far
1971pdf: 311HTML: 4

